RxDoctor Payments DataLook up a doctor →

Lucy Mastrandrea

Pediatric Endocrinology · Buffalo, NYNPI 1760565105

Payments from drug & device makers

$985,561in general payments, 2019–2025

Across 1,571 payments — averaging $627.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$557K
  • Rhythm Pharmaceuticals, Inc.$144K
  • Astrazeneca UK Limited$134K
  • Eli Lilly$72K
  • Dompe Farmaceutici S.p.a.$62K
  • Sanofi US Services Inc.$15K
  • plus $2K from 10 others
$1,247in research payments, 2019–2025

Across 1 payment — averaging $1246.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1K

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$985,561 in reported general payments places this provider in the 95th percentile of 138 pediatric endocrinology providers in New York.

See all pediatric endocrinology providers in New York

Other pediatric endocrinology in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →